{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:56:12Z","timestamp":1790751372397,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Idiopathic sudden sensorineural hearing loss (ISSNHL) is an acute otologic emergency, and hearing recovery remains highly variable and frequently unsatisfactory.\n                      <jats:italic>Acorus tatarinowii<\/jats:italic>\n                      Schott has long been used in traditional Chinese medicine to treat hearing impairment and related auditory disorders. Its essential oil (SCP-oil) has demonstrated anti-inflammatory, antioxidant, and neuroprotective activities in preclinical studies. Advances in local otologic drug-delivery strategies suggest that administration through the external auditory canal may offer a practical, noninvasive approach to local treatment. This study therefore aims to evaluate the efficacy and safety of adjunctive SCP-oil ear-canal packing in patients with ISSNHL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a single-center, randomized, double-blind, placebo-controlled clinical trial to be conducted at Zhejiang Provincial Hospital of Chinese Medicine. The trial has been registered with the International Traditional Medicine Clinical Trial Registry (ITMCTR2026000919). A total of 258 eligible participants will be randomly assigned in a 1:1 ratio to receive conventional therapy combined with either SCP-oil ear-canal packing or glycerin placebo ear-canal packing for 14 consecutive days. The primary outcome is the study-defined total markedly effective rate of hearing recovery at week 2, defined as the proportion of participants achieving complete recovery or marked improvement, as assessed by pure-tone audiometry. Secondary outcomes include the mean improvement in hearing thresholds across the affected frequencies, the hearing-recovery categories, tinnitus severity measured using the Visual Analog Scale (VAS), depressive symptoms assessed using the Self-Rating Depression Scale (SDS), and sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI). Efficacy outcomes will be assessed at baseline and week 2, with an additional safety assessment conducted at week 4. Adverse events will be monitored throughout the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This trial will provide evidence on the efficacy, safety, and tolerability of adjunctive SCP-oil ear-canal packing for ISSNHL, including its effects on hearing recovery and patient-reported outcomes. The findings may also inform the design of future multicenter clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1875920","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:01:02Z","timestamp":1790748062000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjunctive Acorus tatarinowii essential-oil ear-canal packing for idiopathic sudden sensorineural hearing loss: study protocol for a single-center, randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.3389","volume":"17","author":[{"given":"Sibei","family":"Chen","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","place":["Hangzhou, China"]},{"name":"The First Clinical Medical College, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handong","family":"Xu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","place":["Hangzhou, China"]},{"name":"The First Clinical Medical College, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"He","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxia","family":"Tang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivar. Behav. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/antiox11020281","article-title":"Molecular mechanisms and therapeutic potential of \u03b1- and \u03b2-Asarone in the treatment of neurological disorders","volume":"11","author":"Balakrishnan","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.3390\/molecules28176231","article-title":"Make the quality control of essential oils greener: fast enantioselective GC-MS analysis of sweet and bitter Orange as a case study","volume":"28","author":"Bechis","year":"2023","journal-title":"Molecules"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.3390\/molecules26185610","article-title":"Adulteration of essential oils: a multitask issue for quality control. Three case studies: lavandula angustifolia mill., citrus limon (L.) osbeck and Melaleuca alternifolia (maiden and betche) cheel","volume":"26","author":"Capetti","year":"2021","journal-title":"Molecules"},{"key":"B5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jep.2018.11.016","article-title":"Traditional oriental medicine for sensorineural hearing loss: can ethnopharmacology contribute to potential drug discovery?","volume":"231","author":"Casta\u00f1eda","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599819859885","article-title":"Clinical practice guideline: sudden hearing loss (update)","volume":"161","author":"Chandrasekhar","year":"2019","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/coa.14036","article-title":"Spontaneous recovery rate of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis","volume":"48","author":"Chaushu","year":"2023","journal-title":"Clin. Otolaryngol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jpsychores.2013.03.006","article-title":"Mental health in adults with sudden sensorineural hearing loss: an assessment of depressive symptoms and its correlates","volume":"75","author":"Chen","year":"2013","journal-title":"J. Psychosom. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"11314","DOI":"10.3390\/cimb46100673","article-title":"Hepatotoxicity induced by methyl eugenol: insights from toxicokinetics, metabolomics, and gut microbiota","volume":"46","author":"Chen","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12951-025-03368-0","article-title":"Biomaterial-based drug delivery systems in the treatment of inner ear disorders","volume":"23","author":"Cheng","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2022","journal-title":"Clin. Kidney J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3760\/cma.j.cn115330-20260302-00121","article-title":"Guideline for diagnosis and treatment of sudden sensorineural hearing loss (2026 practical edition)","volume":"61","year":"2026","journal-title":"Chin. J. Otorhinolaryngol. Head. Neck Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamaoto.2021.2685","article-title":"Hyperbaric oxygen therapy for patients with sudden sensorineural hearing loss: a systematic review and meta-analysis","volume":"148","author":"Joshua","year":"2022","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamaoto.2018.0658","article-title":"Association of idiopathic sudden sensorineural hearing loss with affective disorders","volume":"144","author":"Kim","year":"2018","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7874\/jao.2024.00024","article-title":"Contemporary review of idiopathic sudden sensorineural hearing loss: management and prognosis","volume":"28","author":"Lee","year":"2024","journal-title":"J. Audiol. Otol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.fct.2014.07.018","article-title":"\u03b2-Asarone (cis-2,4,5-trimethoxy-1-allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-\u03baB signaling and the JNK pathway in LPS activated BV-2 microglia cells","volume":"72","author":"Lim","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1377876","DOI":"10.3389\/fphar.2024.1377876","article-title":"Safety assessment of acori tatarinowii rhizoma: acute and subacute oral toxicity","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jamaoto.2020.0047","article-title":"Intratympanic vs systemic corticosteroids in first-line treatment of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis","volume":"146","author":"Mirian","year":"2020","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fncel.2019.00261","article-title":"Inner ear therapeutics: an overview of middle ear delivery","volume":"13","author":"Patel","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00228-025-03844-4","article-title":"Pentoxifylline uses in inner ear diseases","volume":"81","author":"Ramzi","year":"2025","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.3390\/jcm14082811","article-title":"Current role of the nonsteroid treatment of idiopathic sudden sensorineural hearing loss (ISSNHL): a narrative review","volume":"14","author":"Rodr\u00edguez-Izquierdo","year":"2025","journal-title":"J. Clin. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.joto.2019.07.001","article-title":"Sudden sensorineural hearing loss - a contemporary review of management issues","volume":"15","author":"Singh","year":"2020","journal-title":"J. Otol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599812436449","article-title":"Clinical practice guideline: sudden hearing loss","volume":"146","author":"Stachler","year":"2012","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/jat.4112","article-title":"\u03b1-Asarone, \u03b2-asarone, and \u03b3-asarone: current status of toxicological evaluation","volume":"41","author":"Uebel","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.3390\/molecules28114525","article-title":"Acorus tatarinowii schott: a review of its botany, traditional uses, phytochemistry, and pharmacology","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1090526","DOI":"10.3389\/fphar.2023.1090526","article-title":"Acori tatarinowii rhizoma: a comprehensive review of its chemical composition, pharmacology, pharmacokinetics and toxicity","volume":"14","author":"Wen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"154695","DOI":"10.1016\/j.phymed.2023.154695","article-title":"Essential oil of Acorus tatarinowii schott inhibits neuroinflammation by suppressing NLRP3 inflammasome activation in 3 \u00d7 Tg-AD transgenic mice","volume":"112","author":"Xu","year":"2023","journal-title":"Phytomedicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7787","DOI":"10.1039\/d4tb00676c","article-title":"Biomaterials for non-invasive trans-tympanic drug delivery: requirements, recent advances and perspectives","volume":"12","author":"Xu","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"B29","doi-asserted-by":"publisher","first-page":"356ra120","DOI":"10.1126\/scitranslmed.aaf4363","article-title":"Treatment of otitis media by transtympanic delivery of antibiotics","volume":"8","author":"Yang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.5664\/jcsm.9864","article-title":"Association of sudden sensorineural hearing loss with increased risk of insomnia: a nationwide population-based cohort study","volume":"18","author":"Yeo","year":"2022","journal-title":"J. Clin. Sleep. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jconrel.2005.09.023","article-title":"Gelatin as a delivery vehicle for the controlled release of bioactive molecules","volume":"109","author":"Young","year":"2005","journal-title":"J. Control Release"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2008701","DOI":"10.1002\/adfm.202008701","article-title":"Drug delivery across barriers to the middle and inner ear","volume":"31","author":"Zhang","year":"2021","journal-title":"Adv. Funct. Mater."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1875920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:01:03Z","timestamp":1790748063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1875920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":32,"alternative-id":["10.3389\/fphar.2026.1875920"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1875920","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1875920"}}